149 related articles for article (PubMed ID: 9516375)
1. I heard that the adhesive patch you can wear to prevent motion sickness is available again. Why was it taken off the market?
Mayo Clin Health Lett; 1998 Mar; 16(3):8. PubMed ID: 9516375
[No Abstract] [Full Text] [Related]
2. [An unusual case of psychosis caused by long-term administration of a scopolamine membrane patch. Paranoid hallucinogenic and delusional symptoms].
Rubner O; Kummerhoff PW; Haase H
Nervenarzt; 1997 Jan; 68(1):77-9. PubMed ID: 9132625
[TBL] [Abstract][Full Text] [Related]
3. [Scopolamine plaster caused hallucination. Toxic psychosis in a 10-year-old boy caused by an agent against motion sickness].
Björk M; Wettergren B
Lakartidningen; 1995 Feb; 92(7):638. PubMed ID: 7861858
[No Abstract] [Full Text] [Related]
4. [Model of motion sickness in white mice experiments].
Zhabko EP; Lukomskaia NIa
Aviakosm Ekolog Med; 1997; 31(6):66-8. PubMed ID: 9483286
[No Abstract] [Full Text] [Related]
5. Scopolamine patch can be confusing to the patient and anesthesiologist: a case report.
Elias MA; Abouleish E
Anesthesiology; 1997 Mar; 86(3):743-4. PubMed ID: 9066342
[No Abstract] [Full Text] [Related]
6. Control of simulator sickness in an AH-64 aviator.
Kroll JD
Aviat Space Environ Med; 1989 Dec; 60(12):1202-3. PubMed ID: 2604677
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of transdermal scopolamine against seasickness: a 3-day study at sea.
Attias J; Gordon C; Ribak J; Binah O; Rolnick A
Aviat Space Environ Med; 1987 Jan; 58(1):60-2. PubMed ID: 3814034
[TBL] [Abstract][Full Text] [Related]
8. Transdermal scopolamine withdrawal syndrome.
Feder RE
Clin Neuropharmacol; 1999; 22(2):120. PubMed ID: 10202610
[No Abstract] [Full Text] [Related]
9. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
[TBL] [Abstract][Full Text] [Related]
10. Scopolamine withdrawal syndrome.
Saxena K; Saxena S
Postgrad Med; 1990 Jan; 87(1):63-6. PubMed ID: 2296571
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine.
Patel PN; Ezzo DC
Am J Health Syst Pharm; 2009 Nov; 66(22):2024-6. PubMed ID: 19890085
[TBL] [Abstract][Full Text] [Related]
12. Accidental mydriasis from scopolamine patches.
Rosen NB
J Am Optom Assoc; 1986 Jul; 57(7):541-2. PubMed ID: 3745760
[TBL] [Abstract][Full Text] [Related]
13. Scopolamine patch to prevent seasickness: clinical response vs. plasma concentration in sailors.
Gil A; Nachum Z; Dachir S; Chapman S; Levy A; Shupak A; Adir Y; Tal D
Aviat Space Environ Med; 2005 Aug; 76(8):766-70. PubMed ID: 16110693
[TBL] [Abstract][Full Text] [Related]
14. Scopolamine for prevention of postoperative nausea in gynecologic laparoscopy, a randomized trial.
Einarsson JI; Audbergsson BO; Thorsteinsson A
J Minim Invasive Gynecol; 2008; 15(1):26-31. PubMed ID: 18262140
[TBL] [Abstract][Full Text] [Related]
15. A comparison of motion sickness remedies in severe sea conditions.
Gahlinger PM
Wilderness Environ Med; 2000; 11(2):136-7. PubMed ID: 10921365
[No Abstract] [Full Text] [Related]
16. Evaluation of a new antinauseant drug for the prevention of motion sickness.
Graybiel A; Knepton J
Aviat Space Environ Med; 1977 Sep; 48(9):867-71. PubMed ID: 334151
[No Abstract] [Full Text] [Related]
17. Transdermal scopolamine precipitating narrow-angle glaucoma.
Fraunfelder FT
N Engl J Med; 1982 Oct; 307(17):1079. PubMed ID: 7121520
[No Abstract] [Full Text] [Related]
18. More on Transderm Scop patches.
N Engl J Med; 1984 Nov; 311(21):1377-8. PubMed ID: 6493292
[No Abstract] [Full Text] [Related]
19. Transdermal scopolamine, oral meclizine, and placebo in motion sickness.
Dahl E; Offer-Ohlsen D; Lillevold PE; Sandvik L
Clin Pharmacol Ther; 1984 Jul; 36(1):116-20. PubMed ID: 6734040
[TBL] [Abstract][Full Text] [Related]
20. Transderm scopolamine efficacy related to time of application prior to the onset of motion.
Levy GD; Rapaport MH
Aviat Space Environ Med; 1985 Jun; 56(6):591-3. PubMed ID: 4015572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
